Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Abdul-Ghani

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazoneRalph A DeFronzo, Devjit Tripathy, Muhammad Abdul-Ghani, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2018
Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)John P Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, et al.
Journal of Medical Imaging (Bellingham, Wash.)|July 10, 2015
Fiber orientation measurements by diffusion tensor imaging improve hydrogen-1 magnetic resonance spectroscopy of intramyocellular lipids in human leg musclesSunil K Valaparla, Feng Gao, Giuseppe Daniele, et al.
The Israel Medical Association Journal : IMAJ|July 13, 2006
Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndromeMuhammad Abdul-Ghani, Gamal Nawaf, Fawaz Nawaf, et al.
Diabetes, Obesity & Metabolism|April 14, 2021
Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT studySiham Abdelgani, Curtiss Puckett, John Adams, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Efficacy of Exenatide Plus Pioglitazone Vs Basal/Bolus Insulin in T2DM Patients With Very High HbA1cMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2018
Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFGMariam Alatrach, Christina Agyin, Rucha Mehta, et al.
Biomed Research International|August 17, 2018
The Impact of Vitamin D Deficiency on Retinopathy and Hearing Loss among Type 2 Diabetic PatientsAbdulbari Bener, Mustafa Eliaçık, Hakan Cincik, et al.
Plos One|December 21, 2017
Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjectsRoy Eldor, Luke Norton, Marcel Fourcaudot, et al.
Diabetes, Obesity & Metabolism|July 31, 2020
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar studyMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazoneRalph A DeFronzo, Devjit Tripathy, Muhammad Abdul-Ghani, et al.
The Lancet. Diabetes & Endocrinology|September 19, 2018
Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)John P Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, et al.
Journal of Medical Imaging (Bellingham, Wash.)|July 10, 2015
Fiber orientation measurements by diffusion tensor imaging improve hydrogen-1 magnetic resonance spectroscopy of intramyocellular lipids in human leg musclesSunil K Valaparla, Feng Gao, Giuseppe Daniele, et al.
The Israel Medical Association Journal : IMAJ|July 13, 2006
Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndromeMuhammad Abdul-Ghani, Gamal Nawaf, Fawaz Nawaf, et al.
Diabetes, Obesity & Metabolism|April 14, 2021
Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT studySiham Abdelgani, Curtiss Puckett, John Adams, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Efficacy of Exenatide Plus Pioglitazone Vs Basal/Bolus Insulin in T2DM Patients With Very High HbA1cMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
The Journal of Clinical Endocrinology and Metabolism|October 30, 2018
Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFGMariam Alatrach, Christina Agyin, Rucha Mehta, et al.
Biomed Research International|August 17, 2018
The Impact of Vitamin D Deficiency on Retinopathy and Hearing Loss among Type 2 Diabetic PatientsAbdulbari Bener, Mustafa Eliaçık, Hakan Cincik, et al.
Plos One|December 21, 2017
Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjectsRoy Eldor, Luke Norton, Marcel Fourcaudot, et al.
Diabetes, Obesity & Metabolism|July 31, 2020
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar studyMuhammad Abdul-Ghani, Osama Migahid, Ayman Megahed, et al.
Pageof 10